Literature DB >> 8672533

Type II transglutaminase expression in rabbit articular chondrocytes in culture: relation with cell differentiation, cell growth, cell adhesion and cell apoptosis.

L Borge1, S Demignot, M Adolphe.   

Abstract

Depending on the cell type studied, the involvement of type II transglutaminase (TGase) has been proposed in almost any event of the cell life such as differentiation, apoptosis, growth, aging, cell morphology and adhesion, metastatic capacity or extracellular matrix stabilization. In order to define the field(s) where this enzyme may be implicated in chondrocytes, type II TGase expression was studied in chondrocytes at different passages which differentiated state was modulated by retinoic acid, dihydrocytochalasin B or staurosporin. Results showed that (i) type II TGase expression is not incompatible with type II collagen expression, a main marker of chondrocyte differentiation (ii) type II TGase expression is higher when cells are in the exponential phase of growth than when growth arrested (iii) a high type II TGase expression does not imply that cells are apoptotic although cell apoptosis correlates with increased type II TGase expression (iv) non-adherent cells do not express type II TGase whereas adherent cells do whatever their differentiation state as assessed by type II collagen synthesis. These results suggest that, in articular chondrocytes, type II TGase is specifically implicated in the cell adhesion capacity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672533     DOI: 10.1016/0167-4889(96)00028-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Characterization of the transglutaminase gene family in zebrafish and in vivo analysis of transglutaminase-dependent bone mineralization.

Authors:  Stephanie Deasey; Olga Grichenko; Shaojun Du; Maria Nurminskaya
Journal:  Amino Acids       Date:  2011-08-02       Impact factor: 3.520

2.  Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.

Authors:  T S Johnson; C I Scholfield; J Parry; M Griffin
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

3.  Restoration of the differentiated functions of serially passaged chondrocytes using staurosporine.

Authors:  L Borge; F Lemare; S Demignot; M Adolphe
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

Review 4.  New developments in the pathogenesis of articular cartilage calcification.

Authors:  G A Karpouzas; R A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

5.  Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.

Authors:  G D'Argenio; M Calvani; N Della Valle; V Cosenza; G Di Matteo; P Giorgio; S Margarucci; O Petillo; F P Jori; U Galderisi; G Peluso
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

6.  Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.

Authors:  Kristen A Johnson; David M Rose; Robert A Terkeltaub
Journal:  J Cell Sci       Date:  2008-06-10       Impact factor: 5.285

7.  Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization.

Authors:  M Nurminskaya; C Magee; D Nurminsky; T F Linsenmayer
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

Review 8.  Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis.

Authors:  Hyun Sook Hwang; Hyun Ah Kim
Journal:  Int J Mol Sci       Date:  2015-10-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.